Evidence map›Paper›PMID 30310394›Full record

ArticleKardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery2018

Primary pulmonary sarcoma - long-term treatment outcomes and prognostic factors.

Janusz Gołota, Karolina Osowiecka, Tadeusz Orłowski

Open access · diamondAbstract read
In one paragraph

Article in Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Pulmonary Zebra: Adult Primary Pulmonary Synovial Sarcoma.Case reports in oncological medicine · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Primary pulmonary sarcoma - treatment outcomes depending on the different types of radical operation.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2019
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Janusz GołotaThoracic Surgery Clinical Ward, Municipal Polyclinical Hospital, Olsztyn, Poland.
Karolina OsowieckaDepartment of Surgery, Institute of Lung Diseases and Tuberculosis, Warsaw, Poland.
Tadeusz OrłowskiDepartment of Public Health, University of Warmia and Mazury, Olsztyn, Poland.
University of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrimary pulmonary sarcoma (PPS) is a rare type of non-epithelial malignant tumour of the lungs. Lung sarcomas are usually of metastatic character, originating from the primary tumour located in another organ. Pathomorphological diagnosis is difficult and therefore definitive diagnosis is usually determined after surgical treatment. Five-year survival of radical operated patients is 42-69%.

aimTo evaluate prognostic factors in PPS. MATERIAL AND

methodsTwenty-two patients who underwent surgical treatment between 1994 and 2009 were analysed.

resultsTen types of sarcomas were identified. All 22 analysed patients underwent operations and in 14 (63.6%) cases it was R

conclusionsPrimary radical surgical resection prolongs patient survival. Patients with tumours larger than 5 cm and men have worse prognoses. Future studies conducted on larger groups of patients diagnosed with PPS are necessary.

Indexed as

overall survivalprimary pulmonary sarcomaprognostic factorssurgery

Identifiers

PMID30310394
PMCPMC6180022
OpenAlexW2896749696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.